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Abstract 
Myasthenia gravis (MG) is a rare neuromuscular disease with an autoimmune 
background. It is characterized by the presence of antibodies directed against the 
acetylcholine receptor. Diagnosing MG poses a lot of difficulties because it is characterized 
by high variability of symptoms. The most important symptoms of this disease are weakness 
and excessive muscular fatigue. Diagnosis of the MG requires carrying out a diagnostic tests 
with a broad spectrum. One of the elements of the comprehensive treatment of patients with 
MG is the implementation of appropriate physiotherapeutic procedures. Together with other 
forms of therapy, it alleviates the symptoms of the disease and improves the quality of life of 
people with myasthenia. 
The aim of this work is to present diagnostic methods and physiotherapeutic 
possibilities in one of the neuromuscular diseases - myasthenia gravis. The bibliographic 
databases were searched: PubMed, Polish Medical Bibliography and Medline. Articles in 
Polish and English were used. 
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Introduction 
The development of a neuroscience and a molecular research in recent years has 
allowed us to learn the mechanisms and causes of many diseases, including neuromuscular 
diseases. These are disorders in which the nervous system and muscles function. We include 
myasthenia gravis (MG). Miastenia is a non-hereditary, autoimmune disease of the 
neuromuscular junction with high variability of symptoms [1, 2]. 
It is characterized by the weakening of muscle strength, especially characteristic of 
this disease is the drooping of the eyelid due to muscle weakening of the eyelid. Drooping 
eyelids is the first symptom of disease for 65-70% of patients. Miastenia is a disorder known 
since year 1672. For the first time symptoms of this disease were described by Thomas Willis 
[1, 2]. 
Since then, the level of knowledge on myasthenia gravity has increased, and 
a significant part of the main clinical features have already been described at the end of the 
19th century. The development of medicine caused the discovery in the 20th century of 
antibodies against acetylcholine receptors (AChR). These antibodies are present in the 90% of 
patients [1, 2]. 
Modern methods of immunology and molecular biology have been dynamically 
developing in recent years. Their goal is to find more effective treatments than those we 
currently have. The progress of medicine and newly acquired knowledge have allowed to 
reduce mortality due to myasthenia over ten times. Currently, the incidence of this disorder is 
15 cases per 100,000 people. This means that about 6,000 people are affected in Poland. 
Statistically, women are more often ill. Miastenia is therefore classified as a rare disease [1, 2, 
3]. 
Myasthenia gravis - clinical picture, course of the disease, epidemiology 
Myasthenia gravis (MG) is an acquired autoimmune disease characterized by the 
presence of autoantibodies against neuromuscular junction proteins - the acetylcholine 
receptor (AchR) and the receptor specific tyrosine kinase kinase. During myasthenia, the 
affected cells of the body that serve to destroy dangerous microorganisms, viruses, and other 
foreign elements begin to work against the person himself. They kill the receptors responsible 





Fig. 1. Mechanism of myasthenia [4] 
 
Antibodies bind to receptors, causing their damage. The immunologic etiology of the 
disease is indicated by the higher incidence of autoimmune disorders in patients with 
myasthenia gravis, as well as their first-degree relatives and the relationship between the 
disease and some of the human leukocyte antigens (HLA) - B7, B8 and DR2 [1, 5]. 
This disease can be found worldwide, in every latitude. Occurs with a frequency of 15 
people per 100,000 population. It is estimated that about 6000 patients suffer from MG in 
Poland. People of all ages are ill and the first symptoms can occur as early as the age of two. 
However, the disease most often appears in two peaks, namely mainly women aged 20 to 30 
years, and the majority of men aged 50 to 60 years [3]. 
The first symptoms of the disease most often affects the eye muscles - there is 
a disorder of their movements, double vision and ptosis. The cause of these symptoms is the 
weakening of the eyelid levator muscle. These symptoms are characteristic of the ocular form 
of myasthenia gravis, which is one of MG's forms according to Osserman's clinical  







Table 1. Clinical division of myasthenia gravis according to Osserman [1, 5, 7]. 
The form of 
disease 
Symptoms 
Ocular  Occupation of eyeball muscles, eyelid drooping, image splitting 
Gentle generalized Occupation of muscular, bulging and limb muscles 
Severe generalized The occupation of all muscles to a large extent 
Severe violent Seizure of all muscles to a greater extent than in the form of severe 
generalized, with the occurrence of respiratory disorders, or the 
occurrence of violent first symptoms 
 
In patients with MG, there is also a tendency of bulbar muscles that change speech, it 
becomes quiet with a nasal noise. Weakness of the bulbar muscles is characteristic of a mild 
generalized form. There are difficulties in chewing and swallowing both solid and liquid food, 
there may also be a fall of the mandible, and facial expression is disturbed. A characteristic 
feature of both mild and severe generalized form of MG is apokamnosis, i.e. muscle weakness 
during exercise. Usually muscle weakness occurs and lasts longer at the end of the day [1, 5, 
7]. 
Myasthenia gravis is a disease with a high variability of symptoms. In addition to the 
severity of muscle weakness due to fatigue during a specific effort, the variability of the 
occurrence of symptoms in long periods of time is also observed. Deterioration may be 
caused by hormonal disorders, infections, stress, both physical and mental, some medicines, 
and sometimes there is no specific cause. About 20% of patients in the first year of the disease 
develop spontaneous relapses and remissions. High variability of symptoms makes it 
impossible to plan therapy for more than a few months, and any significant deterioration is an 
indication for neurological consultation and treatment modification. There is a possibility of a 
myasthenic crisis - a rapid and severe exacerbation of the symptoms of myasthenia gravis 
with symptoms of respiratory failure [5, 6, 7]. 
In addition to clinical division, we also distinguish children's characters. Children's 
infancy up to 4 years of age is more common in boys, only in older children there is a 
prevalence of cases among girls [1, 7]. 
In childhood myasthenia disease often begins with isolated ophthalmic symptoms. 
Early-onset birth usually appears in women between 18 and 30 years of age. MG with late 
onset, more often appears in men from 5 to 8 decade of life. The first symptoms occur in 
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people in good condition, usually they are quite rapidly increasing ocular and bulbar 
symptoms [1, 7]. 
The clinical picture and course are not different from those typical of myasthenia 
gravis. This form of myasthenia affects 20% of all patients. MG appearing with the thymoma 
appears equally often in women and men, usually in the age range from 30-74. It is not 
a paraneoplastic syndrome. The clinical picture and electrophysiological examination do not 
differ from typical myasthenia gravis. Also, the severity of the symptoms of the disease and 
the response to conservative treatment are not different from that in a typical myasthenia 
gravis [1, 7]. 
Diagnostics  
Diagnosing myasthenia gravis, especially in the early stages of the disease, is very 
difficult for clinicians. According to the literature [4], up to 20% of patients in the first year of 
the disease were made bad diagnoses. Unambiguous diagnosis of the MG requires different 
tests: neurological, immunological, pharmacological, mediastinal imaging [8, 9, 10]. 
Myasthenia gravis is a disease with various clinical symptoms, therefore during 
diagnosis it should be differentiated with: MS, faster fatigue (eg chronic fatigue syndrome), 
Lambert-Eaton myasthenic syndrome, bulbar SLA, progressive ophthalmoplegia (eg in the 
phthopharyngeal dystrophy), neurasthenia [9, 11, 12]. 
Neurological examination 
The diagnosis process begins with gathering an in-depth interview with the patient. 
During the neurological examination may be found reduced muscle strength, however, in the 
majority of patients in the initial stage of the disease this is not observed [8]. 
Electrophysiological examination 
Performing neuroelectrophysiological tests is an important element in the diagnosis of 
nervous system diseases. Thanks to the analysis of bioelectrical phenomena, the functioning 
of structures of this system can be assessed. Electrophysiological examination allows the 
diagnosis of neuromuscular conduction disorders or their exclusion, however, it does not 
decide on the diagnosis of myasthenia gravis - neuromuscular transmission disorders may also 
occur in other conditions. SFEMG (Single fiber electromyography) and RNS (Repetitive 
Nerve Stimulation) are used for diagnosis of MG [12, 13]. 
Single fiber electromyography (SFEMG) is the most sensitive technique used to assess 
abnormalities in neuromuscular transmission. Electrode with a diameter of 25μm and an 
electromyograph enable registration of extracellular functional potentials of muscle fiber 
during weak contraction. A pair of potentials are studied, which come from various muscle 
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fibers innervated by one motoneuron. The emergence of a second potential in a variable time 
is indicative of disturbances in neuromuscular conduction, and the time difference is called 
"jitter" - it is prolonged in myasthenia [12]. 
Repetitive Nerve Stimulation (RNS), by means of which a selected nerve is stimulated 
by an over-maximal pulse of different frequency (2-5 Hz or 10 Hz and more), followed by a 
motor response from the muscle nerved by the nerve to be examined. The potential 
amplitudes should be similar, and the neuromuscular transmission disorder is found in the 
case of the myasthenic decrement - a decrease in the amplitude of subsequent potentials 
during stimulation by more than 10%. The muscle to be examined should be "clinically 
occupied", because myasthenia does not occupy all muscle groups - the selectivity of the 
neuromuscular block. A minimum of three muscles should be tested. Although this study is 
considered essential in the diagnosis of MG, it is characterized by negative sides. Not always 
a negative result indicates a lack of disease, which is especially characteristic of ocular 
myasthenia. In addition, the test is invasive and unpleasant for patients [8, 12, 13]. 
Immunological examination 
In the immunological diagnosis, antibodies against the acetylcholine receptor are 
determined - present in 70-90% of cases of generalized myasthenia and in 50% of ocular 
myeloma. If the value of antibodies in the blood exceeds 0.4nmol/l, this confirms the 
diagnosis of the disease. However, there are no antibodies of this type in seronegative 
myasthenia. In some cases, antibodies against acetylcholine appear after a certain time, then 
antibodies directed against other muscle fiber proteins play a greater role [2, 8, 9, 14]. 
Other antibodies present in patients with MG are anti-MuSK antibodies or antibodies 
directed against other muscle proteins - titin, ryanodynia. As myasthenia belongs to 
autoimmune diseases, antibodies specific to this type of diseases are also present: anti-
parasite, antinuclear, anti-IgM, antithyroid, anti-muscular [8, 14]. 
Pharmacological examination 
Patients suspected of having MG are given acetylcholinesterase inhibitors - endophon 
or neostigmine. In some patients, the improvement of muscle function is noticeable, in which 
weakness was previously noted. However, this is not a study by which one can make a certain 
diagnosis - a similar response is also found in other diseases, eg peripheral nerve neuropathy 
or brain stem glioma. Noteworthy is the fact that after using Tensilon, muscle performance is 





In the case of MG, imaging of the mediastinum is particularly important. The test 
gives the possibility of finding the presence of the thymus, which disappears under 
physiological conditionsin adulthood, and possible changes in its structure (thymus tumors, 
thymomas). The main purpose of thoracic imaging is not to diagnose the disease, but to 
decide on a possible surgical procedure. The most commonly used imaging method is 
computed tomography. Only the presence of large mass in the mediastinum can be seen in the 
X-ray [8, 11]. 
Physiotherapy 
Performing even simple everyday activities makes patients with myasthenia a big 
problem, which is why few patients are physically active. Non-diseased muscle groups can be 
involved in physical training, and the risk of symptoms appearing characteristic of MG is 
lower [15, 16]. 
Rehabilitation is an inseparable element of the treatment process. Its purpose is to 
restore lost functions or if it is impossible - to limit disability. The rehabilitation program for 
patients with myasthenia gravis should be individually adapter to the needs of the patient and 
take into account the assumptions of the Polish model of rehabilitation, proposed by prof. 
Dega: universality, earliness, comprehensiveness and continuity. All current symptoms and 
the occurrence of disease exacerbations should be taken into account. It should also be 
remembered that the wrong tempo, high intensity of exercises (including running, bends and 
long-lasting exercises) and high temperaturę and air humidity, may exacerbate the symptoms 
of the disease [17, 18]. 
Respiratory rehabilitation 
Weakening of muscles including respiratory muscles may lead to respiratory failure. 
Therefore, it is important to introduce the improvement of breathing exercises in the program. 
In available publications (tab. 2), the authors suggests various forms of rehabilitation - 
inspiratory and expiratory muscle training, breathing membrane training or endurance 
training. All forms of rehabilitation used bring beneficial health effects for patients, which 







Table 2. List of research on respiratory rehabilitation in myasthenia [19, 20, 21]. 
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(group A) and 
inspiratory muscle 
training (group B) 
 
 
The training included 
breathing the membrane 
path and breathing 
through the laced lips 
 
Endurance training 
Study group Group A - 10 people 
Group B - 8 people 
27 patients with 
generalized myasthenia 
gravis. Assigned 






3 months (6 times a 
week for 30 minutes) 
 
8-week training (3 times 
a week for 45 minutes) 
 
4-6 week training (20 





- improvement of the 
strength and 
efficiency of the 
respiratory muscles 
- improvement of 
lung function 
- reduction of 
dyspnoea symptoms 
 
- improving the strength 
of the respiratory 
muscles 
- improvement of 
respiratory efficiency 
- increased mobility of 
the chest 
 
- improving the 
strength of the 
respiratory muscles 
 
Training strengthening muscle strength and endurance 
The progressing muscle fatigue significantly impairs the functioning of patients. It 
may lead to muscular atrophy, therefore it is important to use exercises that improve muscle 
strength and endurance. In a prospective study, Westerberg et al. [22] used physical training 
in 14 people with MG according to the recommendations for healthy people, with individual 
intensity selected. The training included: aerobic exercises (riding a stationary bike), 
endurance, equivalent and stretching. After 12-week training (twice a week for 90 minutes), 
an improvement in muscle strength was observed, and what is important - none of the patients 
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stopped the study due to the deterioration of their health condition. 
In another prospective study [23], 10-week aerobic and resistance training was 
implemented in 10 patients with myasthenia gravis. Muscle strength, physical fitness, muscle 
enzymes and disease-specific enzymes were performed before and after the training period. 
Physical exercise was good tolerated by patients. The level of muscle enzymes remained 
normal, while the disease-specific microRNAs decreased after the training period. 
The positive effect of endurance exercise is also confirmed by Davidson et al. [24] in 
the case of a patient with myasthenia gravis. After 6 weeks of exercise, the muscle strength 
was improved and the degree of fatigue was reduced. It was observed that the patient was not 
always able to perform the number of repetitions of the exercise that was recommended. This 
confirms that a high intensity of exercise for people with myasthenia gravis is not 
recommended, because these patients have faster muscle fatigability. Interestingly, the goal 
for the patient was to return to the game of golf, which proves that the right motivation is an 
important factor in the process of rehabilitation. 
Balance training 
An important part of the rehabilitation process in myasthenia is balance training. 
Patients with MG lead a more sedentary lifestyle compared to healthy people. This affects, 
among other things, the reduction of bone density and, consequently, can lead to falls and 
fractures. During exercise, there are various physiological effects - increased skeletal muscle 
mass, increased number of mitochondria, which in effect improves the efficiency of 
neuromuscular transmission [25]. A study conducted by S.H Wong et al, [26] in Australia in 
2015, confirms the effectiveness of training aimed at improving the balance in people with 
MG. 
Myasthenia gravis and sport 
The fatigue characteristic of myasthenia causes that athletes diagnosed with a disease 
have a problem with physical activity. The available publications contain descriptions of 
individual cases of people who, despite being diagnosed with myasthenia, did not resign from 
sport. Birnbaum et al. [15] describe the case of a 36-year-old woman taking part in marathons. 
During the initial training, the symptoms most often reported by the patient were fatigue and 
dysphagia. After the participation in the marathon and two half-marathons, no additional 
difficulties or exacerbation of already existing symptoms were observed. The authors report 
that one year after diagnosis, the patient was found to have both normal breathing activity and 
endurance of limbs. There were also 6 MWT (6 Minute Walk Test), the results of which were 
in the normal range. During the regular training, occasional eye symptoms and weakness of 
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the right hand appeared in the patient. Schereer et al. [27] in their publication present a 52-
year-old athlete with diagnosed myasthenia gravis. The patient - the runner completed the 
ultramarathon, which lasted for 5 days, which distance was 220 km. Accompanying 
symptoms of the patient were, among others: problems with breathing and swallowing, the 
severity of which decreased during rest and after administration of pyridostigmine. Lower 
limb weakness and fatigue were also noted. 
The described cases show that myastheniais does not have to be an absolute 
contraindication to active sporting, but no specific guidelines have been published on the 
participation in sport by people with myasthenia gravis. 
Summary 
Miastenia gravis is a rarely occurring neuromuscular disease, the diagnosis of which is 
possible due to appropriate diagnostic tests. A characteristic feature of the MG is increased 
muscular fatigue, which is an indication for the implementation of physiotherapy. So far, few 
studies have been published that evaluated the effect of exercise on the functioning of patients 
with MG. In addition, they are carried out among small groups of patients, therefore, the 
results can not be generalized to all patients with myasthenia. 
A clear lack in the literature on the subject regarding the application of specific 
training patterns in myasthenia may result from the fact that the programs should be 
individualized and adapted to the course of the disease. 
The research shows that the combination of rehabilitation and other forms of 
treatment, appropriately selected activities contribute to alleviating the symptoms of the 
disease, improving physical fitness, increasing muscle strength, and thus improving the 
quality of life. There is a need to develop detailed recommendations according to which you 
can plan physical exercises in this group of patients. 
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